Neste trabalho, estão descritos os métodos de seleção, calibração e de determinação dos fatores de correção, as características físicas dos dosímetros termoluminescentes, o procedimento de cálculo para converter a leitura do dosímetro em dose absorvida e a metodologia para se determinar a dose de entrada. Foram investigadas a praticidade e a utilidade das medidas de dose de entrada com os dosímetros termoluminescentes, bem como a exatidão e a reprodutibilidade no fornecimento da dose diária. As medidas de dose de entrada foram realizadas em cinco pacientes com diagnóstico de câncer de mama tratadas com um feixe de fótons de 6 MV. Não foram detectados grandes desvios entre a dose medida e a dose esperada (os valores concordaram em ± 5%), devido à excelente estabilidade do equipamento de tratamento, ao sistema automático de verificação e à boa exatidão no ajuste diário do tratamento. Uma boa precisão pode ser alcançada quando os fatores de correção para cada parâmetro de influência na resposta do dosímetro são cuidadosamente determinados e aplicados para converter o sinal termoluminescente em dose absorvida. O estudo demonstrou a viabilidade do uso dos dosímetros termoluminescentes para a dosimetria in vivo e sua utilidade como parte de um programa de garantia de qualidade em um serviço de radioterapia. / Selection, calibration procedure to convert TLD signal into absorbed dose and physical characteristics at the thermoluminescent dosimeters, as well as the determination of correction factors and the methodology to determine expected entrance dose, are described in this work. Practical aspects and the utility of entrance dose measures with thermoluminescent dosimeters were investigated, as well as the exactness and the reproducibility of the daily dose release. The entrance dose measures were performed in five patients with diagnosis of breast cancer treated with a 6 MV photon beam. The measured dose and the expected dose values agreed in ± 5%, due to excellent treatment equipment stability, to automatic verification system and the good exactness in the daily treatment adjustment. Good precision can be achieved when the correction factors for each parameter of influence in the dosimeter response are carefully determined and applied to convert the thermoluminescent signal into absorbed dose. The study demonstrates the viability of thermoluminescent dosimeters use for in vivo dosimetry and its utility as part of a quality assurance program in a radiation therapy service.

Introdução: A Radioterapia é frequentemente utilizada no tratamento do câncer, seja como uma modalidade simples ou em combinação com outras modalidades, tais como a cirurgia e a quimioterapia. Com o objetivo de eliminar células não desejadas no organismo humano, utiliza-se de radiações ionizantes para provocar a destruição de células tumorais pela absorção da energia da radiação incidente. A principal dificuldade encontrada em radioterapia é que as células tumorais não são tratadas isoladamente, isto é, o dano da radiação não é restrito somente às células tumorais, mas afeta também as células normais. Assim sendo, é essencial que a dose de radiação liberada nos tecidos normais seja tão baixa quanto possível para minimizar o risco de efeitos colaterais provocados pelos tratamentos radioterápicos. Objetivos: O objetivo deste trabalho é a caracterização de dosímetros semicondutores e dosímetros termoluminescentes e suas aplicações em técnicas não convencionais de Radioterapia. A partir da caracterização será possível a implementação dos dosímetros como sistema de dosimetria in vivo em teleterapia com feixe de fótons, visando atender as necessidades prementes do Serviço de Radioterapia do HCFMRP em implantar a técnica de irradiação de corpo inteiro e em realizar o controle de dose administrada ao paciente. Metodologia e Resultados: Diodos semicondutores foram caracterizados de acordo com o fator campo, angulação, taxa de dose, temperatura e fator bandeja, para obtenção dos fatores de correção. Verificou-se que a variação da resposta dos diodos com a temperatura, angulação e taxa de dose não foi significativa. Fatores campo foram calculados e registrados para campos de 3x3 cm 2 a 40x40cm 2 , onde se observou aumento na leitura do diodo com o aumento no campo. A resposta com a taxa de dose apr esentou pouca variação (de 100cGy/min para 300cGy/min a variação foi menor que 1,2%). O fator bandeja encontrado foi de 0,95±0,01 demonstrando que a presença da bandeja provoca diminuição na resposta do detector. Após a caracterização, os diodos foram calibrados em setup TBI para determinação dos fatores de calibração para cada espessura simulada do paciente (DLL). A dosimetria in vivo foi realizada em 3 pacientes submetidos ao tratamento de TBI do HCFMRP. A diferença percentual máxima entre as medidas com diodo e o valor nominal de dose foi de 3,6%, o que está de acordo com o recomendado pelo ICRU (+/- 5%). Os resultados demonstram a viabilidade e confiabilidade da técnica de dosimetria com diodos semicondutores para Controle de Qualidade de dose em tratamento de TBI. Ainda, dosímetros termoluminescentes foram caracterizados quanto à homogeneidade do grupo e a linearidade. Os fatores de calibração individuais foram encontrados e os dosímetros foram aplicados em simulações em setup TBI. Os cálculos de dose das simulações realizadas com os termoluminescentes inseridos nos orifícios de um OSA demonstraram concordância com os valores nominais de dose. Para as regiões do tórax superior e inferior, onde os TLD receberam doses mais elevadas (>150cGy), recomendou-se a utilização de compensadores de dose, para a prática clínica.Uma câmara de ionização foi utilizada como dosímetro de referência em todas as etapas de calibração e caracterização dos diodos e termoluminescentes. Conclusões: Este estudo mostrou que, para tratamentos de irradiação de corpo inteiro, quando o paciente estiver sendo preparado para um transplante de medula óssea, e o planejamento necessitar de uma grande eficácia na distribuição de dose, a metodologia com aplicações de dosímetros semicondutores apresenta-se como uma alternativa viável, precisa e de grande importância para o controle dosimétrico. Assim, ficou evidenciada a importância da utilização do diodo para o Controle de Qualidade, na avaliação da dos e a ser ministrada ao paciente, pelo menos em toda primeira fração de tratamento de TBI. Além disso, ficou demonstrada a aplicabilidade dos dosímetros termoluminescentes para controle dosimétrico, demonstrando o valor da dosimetria termoluminescente como um sistema de verificação de dose e sua eficácia como parte de um programa de garantia de qualidade em Radioterapia. A caracterização dos termoluminescentes evidenciou a possibilidade de aplicação da técnica TL em dosimetria in vivo. / Introduction: Radiation therapy is often used in cancer treatment, either as a single modality or in combination with other modalities, such as surgery and chemotherapy. Aiming to eliminate unwanted cells in the human body, radiation therapy uses ionizing radiation to cause destruction of tumor cells by absorbing the energy of the incident radiation. The main difficulty in radiation therapy is that tumor cells are not separately treated. The radiation damage is not restricted solely to tumor cells, but also affects normal cells. Therefore, it is essential that the radiation dose released in normal tissues is as low as possible to minimize the risk of side effects caused by radiotherapy treatments. Objectives: The objective of this work is the characterization of semiconductor dosimeters and thermoluminescent dosimeters and their applications in non -conventional radiotherapy techniques. After characterization it will be possible to implement the dosimeters as a system of in vivo dosimetry in radiotherapy with photon beam, to meet the pressing needs of the Radiotherapy Service of HCFMRP in deploying the technique of total body irradiation and make the control of dose administered to the patient . Methodology and Results: Semiconductor diodes were characterized according to the field factor, angle, dose rate, temperature and tray factor to obtain the correction factors. It was found that the variation of the response of the diodes with temperature, angle and dose rate was not significant. Field factors were calculated and recorded for fields from 3x3 cm 2 to 40x40cm 2 , wher e there was an increase in the reading of the diode with increasing field. The response with dose rate showed small variation (from 100cGy/min to 300cGy/min the variation was less than 1.2%). The tray factor was 0.95 ± 0.01 demonstrating that the tray decreases detector response. After characterization, the diodes were calibrated in TBI setup for determining the calibration factors for each simulated patient thickness (latero-lateral distance). The in vivo dosimetry was performed in 3 patients undergoing TBI treatment in HCFMRP. The maximum percentage difference between the measurements and the diode nominal dose was 3.6%, which is consistent with that recommended by ICRU (+ / - 5%). The results demonstrate the feasibility and reliability of the dosimetry technique with semiconductor diodes for dose quality control in TBI treatments. Still, dosimeters were characterized by group homogeneity and linearity. The calibration factors were found and individual dosimeters were applied in simulations with TBI setup. The dose calculation of simulations performed with the thermoluminescent inserted in holes of the phantom showed agreement with the nominal dose. For regions of the upper and lower thorax where TLD received higher doses (> 150cGy) it was recommended the use of compensating dose in clinic. An ionization chamber dosimeter was used as reference in all stages of calibration and characterization of diodes and thermoluminescents. Conclusions: This study showed that, for total body irradiation treatments, when the patient is being prepared for a bone marrow transplant, and planning requires a great effect on the dose distribution, the methodology with semiconductor dosimeters presented a viable alternative, and has great importance for the dosimetric control. The study proved the importance of diode semiconductors for quality control, for evaluation of the dose to be administered to the patient, at least throughout the first fraction of TBI treating. Furthermore, it was demonstrated the applicability of TLD for control quality, demonstrating the value of thermoluminescent dosimetry as a dose verification system and its effectiveness as part of a program of quality assurance in radiotherapy. The characterization of thermoluminescent showed the possibility of applying the TL technique in in vivo dosimetry.

Background: In an ongoing study conducted at Karolinska Institutet & Karolinska University Hospital, Positron Emission Tomography (PET)/Computed Tomography (CT) scans are performed on patients with tibia fractures and deformations treated with Taylor Spatial Frames (TSFs) in order to monitor their bone remodeling progress. Each patients receive an administration of approximately 2 MBq/kg bodyweight of Na18F associated with PET scans on two sessions, six and twelve weeks after the attachment of the TSF. These PET/CT scans provide information about the progress of the healing bone and can be used to estimate the optimal time point for de-attachment of the TSF. The Standardized Uptake Value (SUV) is used as a measure of the rate of bone remodeling for these patients, however, there is a need for verification of this practice by a method independent of the PET scanner. Furthermore, information regarding the biodistribution of the Na18F throughout the body of these patients and the effects of the TSF on the CT scan X‑rays is required. Additionally, an investigation of alternative methods that have the potential to provide similar information with a lower absorbed dose to the patients is desirable. Materials and methods: Thermoluminescent Dosimeters (TLDs) were attached on the skin at the position of the heart, urinary bladder, femurs, fracture, and the contralateral tibia of twelve patients during the first one hour and five minutes after the administration of the Na18F. Additional TLD measurements were performed during the CT scan of two of these patients. From the PET scan images, SUVs at the fracture site of these patients were collected. An investigation of the possibility of exploiting the “naturally” occurring bone seeking radionuclide Strontium-90 (90Sr) in the human body to gain information about the fracture site was undertaken. Using a 90Sr source, three different detection techniques were evaluated and a practical methodology for in vivo measurements on the tibia fracture patients was developed. As it was concluded that TLD based measurements were the most suitable technique for this purpose, and it was tested on five patients with tibia fractures. Results: From the collected TLD data, it was concluded that for these patients the urinary bladder is the organ receiving the greatest amount of absorbed dose and the organ most affected as the administered activity exceeds 2 MBq/kg. On average, a three times higher surface dose was measured on the tibia fracture compared to the un-fractured tibia. A linear relationship between the surface dose and SUVmax was shown. A strong positive correlation between the activity concentration at the fracture site and the amount of injected activity was found, and it was demonstrated that this also affects the SUVs. For patients who were administered different amounts of Na18F for the two PET scans, maximum activity concentrationwas less affected than mean activity concentration. It was concluded that TSF’s effect on the scatter of the X-rays to organs higher up in the body is negligible. Regarding “naturally” occurring 90Sr in the human body, no higher activity at the fractured tibia compared to the non‑fractured tibia could be found. Conclusions: This project assessed the accumulation of Na18F in the fracture site of patients treated with TSF by a method independent of the PET scanner. The methodology of using SUVs as an indicator for bone remodeling was verified. It was shown that the uptake of Na18F by the fracture site is strongly correlated to the amount of injected activity. The importance of considering the amount of injected activity when evaluating and comparing SUVs was highlighted. In vivo measurements using LiF:Mn TLDs did not indicate any quantifiable higher concentration of 90Sr at the fracture in the tibia bone.

Brachytherapy is a form of radiotherapy in which radioactive sources are placed at short distances from, or even inside the target volume. The use of high dose rate brachytherapy is a widely accepted and clinically proven treatment for some stages of prostate cancer. The aim of this project was to investigate potential improvements on two of the most important aspects of high dose rate (HDR) and pulsed dose rate (PDR) prostate brachytherapy - prostate definition and treatment delivery verification. The use of magnetic resonance (MR) imaging in addition to the conventional computed tomography (CT) imaging methods currently used routinely for brachytherapy planning may provide some benefit in accurately defining the prostate and surrounding critical structures. The methods used in this project involved analysis of data sets provided by two Radiation Oncologists. The results presented showed inter-observer and intra-observer variations in the size and shape of the prostate, as well as analysis of the dosimetric differences that may be reported due to the differences in prostate size and shape. The results also included analysis of critical structure dosimetry - dose to the surrounding radio-sensitive rectum and urethra. In summary, the results showed that the prostate was defined to be smaller using MR imaging than CT, however the consistency between Oncologists was not significantly improved using MR imaging. MR imaging may be useful in reducing the dose to normal tissue surrounding the prostate and in obtaining better coverage of the smaller target volume, without compromising the critical structures. The use of LiF:Mg,Ti thermoluminescent dosimeters (TLDs) is a potential avenue for in vivo dose verification of an HDR or PDR prostate brachytherapy treatment plan. This project included a phantom study of these TLDs with the aim to determine their feasibility for clinical use. Cylindrical TLD rods (6 mm length x 1 mm diameter) were used, as these fit inside the brachytherapy needles implanted into the prostate, and therefore had potential to be used clinically to verify the dose delivered in the prostate. This study was extended to include determination of a correction factor to allow an independent radiation source (6 MV photon beam from a linear accelerator) to be used to obtain control readings for this relative dosimetric method. The results showed these TLDs to be a promising in vivo dosimeter for prostate brachytherapy with potential errors in the order of 4%. Their potential lies in the fact that they could detect and flag significant calculation errors in treatment plans, and they utilise equipment used routinely for external beam radiotherapy dosimetry in many treatment facilities, reducing the cost of implementing such a procedure.

Made available in DSpace on 2014-10-09T12:46:32Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T13:56:07Z (GMT). No. of bitstreams: 1 08286.pdf: 4148498 bytes, checksum: f9d73111bc4c47c409ba95ffcaec8d14 (MD5) / Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) / Dissertacao (Mestrado) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP / FAPESP:99/06632-0

Made available in DSpace on 2014-10-09T12:40:59Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T13:56:12Z (GMT). No. of bitstreams: 1 03971.pdf: 6395832 bytes, checksum: 1ba307bbba2500ce19a93c570d8687bf (MD5) / Tese (Doutoramento) / IPEN/T / Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP

Radiotherapy has commonly been utilised to cure cancer for more than a century. It is counted among the fundamental branches of medicine and represents an effective local or locally-regional method of curing both cancer and some non-cancerous conditions. It utilises ionising radiation which unfortunately eliminates tumour cells along with healthy ones. This is why a wide range of harmful effects of the radiation can be observed on humans. Patients treated with radiotherapy are in some cases monitored with dosimeters so that the intended dose can be compared with what is really absorbed. Nemocnice České Budějovice, a. s. monitors the dose in expected locations of non-homogeneous irradiation using the aforementioned TL dosimeters during the process of rotary irradiation of Mycosis fungoides. Before actually being used in an in vivo dosimetry, these dosimeters must be properly calibrated and have their sensitivity adjusted. Other than that, they are fairly easy to use, do not require much time or money invested and are able to constantly monitor the dose received by a patient treated with rotary irradiation. This diploma thesis discusses the usage of TL dosimeters to measure non-homogeneity of irradiation. It therefore compares the doses received by patients in various parts of the body during irradiation by the TSEI method. These 22 irradiated patients had thorough measurements taken of the doses they received in the so-called black hole region, their axillae and neck while holding their arms up and with arms loosely positioned close to the body. The thesis also suggests the possibility of the dosimeters being used by the integrated emergency service to assist during rescues and demolitions performed in emergency situations when a leak of ionising radiation occurs. Using TL dosimeters would mean more precise measurements of the dose received by the involved personnel in various parts of their body. If a patient is treated with the TSEI method, the dose received is monitored in a reference point, critical areas and areas with residual infiltrations or tumours. Doses measured in critical areas indicate that should the acral parts of limbs be left uncovered, they absorb larger doses than the rest of the body. They thus exceed the intended dose significantly. In the case of fingers, the dose tends to reach as much as 3 Gy. Depending on clinical picture, the attending physician determines whether special covering should be used. This covering reduces the doses received to merely a few tenths of a Gy. There also tends to be a large difference in absorbed doses in axillar areas and the neck, depending on whether the patient's arms are held up or close to the body respectively. Test results indicate that holding arms up or keeping them close to the body on a particular side have always had a profound effect on the dose absorbed by the patient in this particular area. This means that the position of the body greatly influences how much is absorbed in various parts of the body. TL dosimeters are also used in other areas than in vivo dosimetry in radiotherapy. An example of this could be determining the dose received in upper limbs of the workers monitored with thermoluminescent dosimeters in the form of bracelets or rings. They also serve to monitor the external irradiation of persons within the limits of the Czech Republic (TLD network). In radiation therapy, both the doses in skin and body are taken into account when conducting measurements. Depending on the data extracted, it is then possible to assess the course of treatment and ensure safe implementation of ionising radiation. Integrated emergency service teams deployed in cases of radiation emergencies are not considering using TL dosimeters so far, although they could most likely be used to ascertain the exact doses absorbed. Further research would however need to be conducted to either confirm or disprove the benefits of using TLD.

A dosimetria in vivo têm se tornado um papel importante para o tratamento da irradiação total da pele dentro de um rigoroso programa de garantia de qualidade que deve ser parte integrante nos departamentos radioterápicos. A dosimetria em TSI é difícil, devido à complexidade do tratamento em avaliar a uniformidade da dose e medir a dose absorvida em profundidades rasas em toda extensão da superfície cutânea, tendo como consequência uma ampla variação na distribuição da dose. Os TLDs tem provado ser muito úteis para a distribuição e verificação da dose prescrita para o paciente, pois a dose pode diferir de local para local devido a geometria do corpo do paciente, sobreposições de estruturas e assimetrias do campo de radiação. A utilização de TLDs in vivo pode identificar variações da dose prescrita por apresentarem uma grande exatidão e precisão nas medidas. Nos setores de radioterapia vêm sendo empregado vários tipos de dosímetros, os mais utilizados são o Flureto de Lítio (TLD-100), onde obtém uma longa história neste tipo de aplicação. Novos materiais dosímetricos vêm ganhado grande importância na aplicação da dosímetria de feixes clínicos de elétrons, como o Sulfato de Cálcio dopado com Disprósio (TL) e o Óxido de Alumínio dopado com Carbono (OSL), este trabalho avalia o desempenho dosímetrico dos respectivos dosímetros termoluminescentes e a luminescência opticamente estimulada na aplicação da dosímetria de feixes clínicos de elétrons utilizados na irradiação total da pele. / In vivo dosimetry has become an important role for the treatment of total skin irradiation within a rigorous quality assurance program that should be an integral part of the radiotherapy departments. TSI dosimetry is difficult because of the complexity of the treatment in assessing dose uniformity and measuring the dose absorbed at shallow depths throughout the skin surface extent, resulting in a wide variation in dose distribution. The TLDs have proven to be very useful for the distribution and verification of the dose prescribed for the patient as the dose may differ from place to place due to patient body geometry, overlapping of structures and asymmetries of the radiation field. The use of TLDs in vivo can identify variations in the prescribed dose because its measurement accuracy and great precision. Several types of dosimeters have been used in the radiotherapy sectors, the most commonly used are Lithium Fluride (TLD-100), where it obtains a long history in this type of application. New dosimetric materials have gained great importance in the dosimetry of clinical electron beams, such as Dysprosium-doped Calcium Sulphate (TL) and Carbon doped (OSL) based Aluminum Oxide, This work evaluates the performance of the respective thermoluminescent dosimeters and the optically stimulated luminescence in the dosimetry of clinical electron beams used in total irradiation of the skin.

Made available in DSpace on 2014-10-09T12:53:45Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T13:58:52Z (GMT). No. of bitstreams: 1 12332.pdf: 1933142 bytes, checksum: 5bc7418723d034bba58a679eb1851ab0 (MD5) / Dissertação (Mestrado) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN-CNEN/SP

Made available in DSpace on 2014-10-09T12:53:02Z (GMT). No. of bitstreams: 0 / Made available in DSpace on 2014-10-09T13:58:56Z (GMT). No. of bitstreams: 0 / Dissertação (Mestrado) / IPEN/D / Instituto de Pesquisas Energeticas e Nucleares - IPEN/CNEN-SP